Nathan

@KFFHealthNews @ArthurAllen202 Forgive the basic question, but why does low supply and high demand not quickly drive the cost of generics up to increase profits again? Is it because of slow moving price negotiation with insurers?

Alarming discoveries during an FDA inspection of an Indian pharmaceutical factory left doctors and their cancer patients with impossible choices, reports @ArthurAllen202. kffhealthnews.org/news/article/d…